48 related articles for article (PubMed ID: 14696220)
1. Mapping cyclic change of regional myocardial blood volume using steady-state susceptibility effect of iron oxide nanoparticles.
Wu EX; Tang H; Wong KK; Wang J
J Magn Reson Imaging; 2004 Jan; 19(1):50-8. PubMed ID: 14696220
[TBL] [Abstract][Full Text] [Related]
2. High field magnetic resonance imaging evaluation of superparamagnetic iron oxide nanoparticles in a permanent rat myocardial infarction.
Chapon C; Franconi F; Lemaire L; Marescaux L; Legras P; Saint-André JP; Denizot B; Le Jeune JJ
Invest Radiol; 2003 Mar; 38(3):141-6. PubMed ID: 12595793
[TBL] [Abstract][Full Text] [Related]
3. Cyclic variation of T1 in the myocardium at 3 T.
Wansapura J; Gottliebson W; Crotty E; Fleck R
Magn Reson Imaging; 2006 Sep; 24(7):889-93. PubMed ID: 16916706
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of global and regional left ventricular function with a 16-slice spiral-CT using two different software tools for quantitative functional analysis and qualitative evaluation of wall motion changes in comparison with magnetic resonance imaging].
Koch K; Oellig F; Kunz P; Bender P; Oberholzer K; Mildenberger P; Hake U; Kreitner KF; Thelen M
Rofo; 2004 Dec; 176(12):1786-93. PubMed ID: 15573290
[TBL] [Abstract][Full Text] [Related]
5. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
Amano Y; Takayama M; Takahama K; Kumazaki T
J Magn Reson Imaging; 2004 Oct; 20(4):595-600. PubMed ID: 15390225
[TBL] [Abstract][Full Text] [Related]
6. Applications of ultrasmall superparamagnetic iron oxide contrast agents in the MR study of animal models.
Wu EX; Tang H; Jensen JH
NMR Biomed; 2004 Nov; 17(7):478-83. PubMed ID: 15526349
[TBL] [Abstract][Full Text] [Related]
7. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
Martin AR; Thompson RB; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
[TBL] [Abstract][Full Text] [Related]
8. Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI.
Lüdemann L; Schmitt B; Podrabsky P; Schnackenburg B; Böck J; Gutberlet M
Eur J Radiol; 2007 May; 62(2):247-56. PubMed ID: 17188443
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice.
Wu EX; Tang H; Asai T; Yan SD
Neurosci Lett; 2004 Jul; 365(3):223-7. PubMed ID: 15246553
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional T1 mapping of the mouse heart using variable flip angle steady-state MR imaging.
Coolen BF; Geelen T; Paulis LE; Nauerth A; Nicolay K; Strijkers GJ
NMR Biomed; 2011 Feb; 24(2):154-62. PubMed ID: 20960583
[TBL] [Abstract][Full Text] [Related]
11. MRI of blood volume with superparamagnetic iron in choroidal melanoma treated with thermotherapy.
Krause MH; Kwong KK; Gragoudas ES; Young LH
Magn Reson Imaging; 2004 Jul; 22(6):779-87. PubMed ID: 15234446
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous assessment of left-ventricular infarction size, function and tissue viability in a murine model of myocardial infarction by cardiac manganese-enhanced magnetic resonance imaging (MEMRI).
Hu TC; Bao W; Lenhard SC; Schaeffer TR; Yue TL; Willette RN; Jucker BM
NMR Biomed; 2004 Dec; 17(8):620-6. PubMed ID: 15761951
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction.
Yang Z; Berr SS; Gilson WD; Toufektsian MC; French BA
Circulation; 2004 Mar; 109(9):1161-7. PubMed ID: 14967719
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of regional myocardial function using automated wall motion analysis of cine MR images: Contribution of parametric images, contraction times, and radial velocities.
Kachenoura N; Redheuil A; Balvay D; Ruiz-Dominguez C; Herment A; Mousseaux E; Frouin F
J Magn Reson Imaging; 2007 Oct; 26(4):1127-32. PubMed ID: 17896377
[TBL] [Abstract][Full Text] [Related]
15. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
[TBL] [Abstract][Full Text] [Related]
16. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
17. Myocardial perfusion imaging based on the blood oxygen level-dependent effect using T2-prepared steady-state free-precession magnetic resonance imaging.
Fieno DS; Shea SM; Li Y; Harris KR; Finn JP; Li D
Circulation; 2004 Sep; 110(10):1284-90. PubMed ID: 15326062
[TBL] [Abstract][Full Text] [Related]
18. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts.
Positano V; Pepe A; Santarelli MF; Scattini B; De Marchi D; Ramazzotti A; Forni G; Borgna-Pignatti C; Lai ME; Midiri M; Maggio A; Lombardi M; Landini L
NMR Biomed; 2007 Oct; 20(6):578-90. PubMed ID: 17205488
[TBL] [Abstract][Full Text] [Related]
19. Balanced steady-state free precession fMRI with intravascular susceptibility contrast agent.
Zhou IY; Cheung MM; Lau C; Chan KC; Wu EX
Magn Reson Med; 2012 Jul; 68(1):65-73. PubMed ID: 22127794
[TBL] [Abstract][Full Text] [Related]
20. Monitoring angiogenesis in brain using steady-state quantification of DeltaR2 with MION infusion.
Dunn JF; Roche MA; Springett R; Abajian M; Merlis J; Daghlian CP; Lu SY; Makki M
Magn Reson Med; 2004 Jan; 51(1):55-61. PubMed ID: 14705045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
